AI For Pharma Growth
by Dr Andree Bates
E242: The diagnostic room: HTA Expectations for AI-Generated…
About this podcast
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results.
This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets to building results in a pharma company using AI and alert you to some fascinating new tools and applications to benefit you and your company.
As the author of many peer-reviewed journals in pharma AI, and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI, futuretech, healthcare and pharma to help you to navigate through the, sometimes confusing, but magical world of AI powered tools to achieve real-world results.
This podcast features many experts who have developed powerful AI-powered tools that are the secret behind some time-saving and supercharged revenue-generating business results. Those who share their stories and expertise show how AI can be applied to Discovery, R&D, clinical trials, market access, medical affairs, regulatory, market research, business insights, sales, marketing, including digital marketing, and so much more.
Episodes
The newest 20 of 244 episodes
- E242: The diagnostic room: HTA Expectations for AI-Generated Evidence: NICE, CDA-AMC and the EU JCA Principles · 37 min · Episode 242In this solo episode of AI For Pharma Growth, Dr Andree Bates explores what health technology assessment bodies now expect when AI is used to generate, analyse or support…
- E241: Beyond the Survey: How Generative AI Captures the Patient Voice at Scale — and Why It's Pharma's Next Growth Lever · 35 min · Episode 241In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Mattia Marco Caruson, co-founder and CEO of mama health, about how generative AI is changing the way pharma…
- E240: How secure and compliant data collaboration accelerates research and medical science · 28 min · Episode 240In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Dr. Kurt Rohloff, co-founder and CEO of Duality Technologies, about how privacy-enhancing technologies could…
- E239: How to Speed Up Drug Development Without Compromising Compliance · 35 min · Episode 239In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Clara Bernardes, co-founder and CSO of Biorce, about how AI can accelerate clinical development without…
- E238: The diagnostic room: The Fifteen Failures Only Human Judgement Catches · 39 min · Episode 238In this solo episode of AI For Pharma Growth, Dr Andree Bates explores one of the biggest blind spots in pharma AI: the failures that can survive a normal review process even…
- E237: Beyond the Pill: How AI is Unlocking the Preventative Medicine Opportunity Pharma Can't Afford to Miss · 30 min · Episode 237In this episode of AI For Pharma Growth, Dr Andree Bates speaks with cancer biologist and health educator Rebecca Maff about how AI could help shift healthcare from treating…
- E236: Why 90% of Trials Still Fail — and What AI Can (and Can't) Fix · 34 min · Episode 236In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Raviv Pryluk, co-founder and CEO of PhaseV, about why so many clinical trials still fail and where AI can…
- E235: AI created a trust crisis and nobody is talking about it · 31 min · Episode 235In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Dan Pratl, founder and CEO of Quadron Inc, about a trust problem emerging as AI moves deeper into pharma: how…
- E234: The contrarian case for physics over data: can deterministic, training-free models beat ML in lead optimization? · 44 min · Episode 234In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Dr. Jacek Marczyk, co-founder and CEO of BioDynLab, about a contrarian view of computational drug discovery…
- E233: The Diagnostic Room: The AI Capability Problem Pharma Hasn't Named · 43 min · Episode 233In this solo episode of AI For Pharma Growth, Dr Andree Bates explores the AI capability problem pharma has not properly named: training that works in the room, but fails to hold…
- E232: The Early Readout: Upgrading the Interim Analysis to Catch Futility and Success Years Sooner · 28 min · Episode 232In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Tom Coates, CEO of Presentient, about why interim analysis in clinical trials is ready for a major upgrade…
- E231: The Diagnostic Room: You didn't have an AI problem. You had a capability problem. · 37 min · Episode 231In this solo episode of AI For Pharma Growth, Dr Andree Bates explores why many pharma teams do not have an AI problem at all. They have a capability problem. Dr Andree starts…
- E230: The Last Untouched Dataset · 24 min · Episode 230In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Nijat Ahmadov, CEO of Nucs AI, about molecular imaging as one of pharma’s most underused data assets. Nijat…
- E229: From Reactive to Proactive: What a QP's Job Should Actually Look Like in 2026 · 33 min · Episode 229In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Jitesh Halai, founder and CEO of OneSC, about what the Qualified Person role should look like in a more…
- E228: The Diagnostic Room: "We're Doing AI" Is Not a Board Answer · 40 min · Episode 228In this solo episode of AI For Pharma Growth, Dr Andree Bates explains why “we’re doing AI” is not a credible board answer, and why activity, pilots and steering committees are…
- E227: From Bench to Boardroom: How One Geneticist is Quietly Reshaping the Future of Healthcare · 34 min · Episode 227In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Bret Bostwick from Breyer Capital about the rare path from genetics, clinical medicine and drug development…
- E226: The AI Deal Scout: How Machine Intelligence Is Reshaping Biopharma Business Development · 28 min · Episode 226In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Smbat Rafayelyan, founder and CEO of Bioneex, about how AI is reshaping biopharma business development, deal…
- E225: The 80% Nobody Talks About: Building AI Governance That Survives a Pharma Audit · 32 min · Episode 225In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Nuno Valério, Head of Innovation, R&D Quality at Merck Healthcare, about the part of AI governance most…
- E224: The Diagnostic Room: The Financial Case Your CFO Actually Needs to See Before Approving Your AI Strategy · 33 min · Episode 224In this solo episode of AI For Pharma Growth, Dr Andree Bates tackles one of the biggest reasons pharma AI strategies stall: they are not presented in the financial language a…
- E223: From Population Models to Personal Intelligence: Rethinking Biological Data · 35 min · Episode 223For most of modern medicine, biological data has been built around population averages: what people like you might experience, rather than what you personally will. In this…







